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ProteomeSnake venoms contain serine proteinases that are functionally similar to thrombin and speciﬁcally cleave ﬁbrin-
ogen to convert it into ﬁbrin or activate platelets to aggregation. PA-BJ is a serine proteinase from Bothrops
jararaca venom that promotes platelet aggregation and this effect ismediated by the G-coupled protein receptors
PAR1 and PAR4. In this study we describe an improved procedure to obtain PA-BJ from B. jararaca venom that
uses less chromatographic steps, and, interestingly, results in the isolation of eight proteoforms showing slightly
different pIs and molecular masses due to variations in their glycosylation levels. The identity of the isolated PA-
BJ forms (1–8) was conﬁrmed by mass spectrometry, and they showed similar platelet-activating activity on
washed platelet suspensions. N- and O-deglycosylation of PA-BJ 1–8 under denaturing conditions generated var-
iable electrophoretic proﬁles and showed that some forms were resistant to complete deglycosylation. Further-
more, N- and O-deglycosylation under non-denaturing conditions also showed different electrophoretic proﬁles
between the PA-BJ forms and caused partial loss of their ability to cleave a recombinant exodomain of PAR1 re-
ceptor. In parallel, three cDNAs encoding PA-BJ-like enzymes were identiﬁed by pyrosequencing of a B. jararaca
venom gland library constructedwith RNA froma single specimen. Taken together, our results suggest that PA-BJ
occurs in the B. jararaca venom inmultiple proteoforms displaying similar properties upon platelets regardless of
their variable isoelectric points, molecular masses, carbohydratemoieties and susceptibility to the activity of gly-
cosidases, and highlight that variability of speciﬁc venom components contributes to venom proteome
complexity.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Snake venom proteomes are complex mixtures comprised of dis-
tinct protein families and peptides with biological activity. The compo-
sition of snake venoms is a result of multiple factors, and its inherent
variability is an intriguing aspect of the evolution of venomous snakes,
which is often related to environmental and ecological traits, and may
change from species to species. Although there is not a general pattern,
the causes of variability are often related to the snake diet in addition to
geographical and biological factors, such as sexual dimorphism, and on-
togenetic changes in diet habits [1–7]. In a recent investigation of the
mechanisms governing venom variation in six relatedmedically impor-
tant viperid snakes (Echis ocellatus, Echis coloratus, Echis pyramidum
leakeyi, Echis carinatus sochureki, Bitis arietans and Cerastes cerastes) it
has been demonstrated that different levels of toxin transcription,oxinologia Aplicada, Instituto
razil. Tel.: +55 11 2627 9731;
.T. Serrano).translation, and posttranslationalmodiﬁcation have a signiﬁcant impact
on the resulting proteome [8].
Variability of speciﬁc venom components has frequently been ob-
served. Phospholipases A2 and serine proteinases are among the most
abundant enzymes found in snake venoms and diverse proteoforms of
these enzymes have been identiﬁed which vary in their biophysical
and biochemical properties [9–12]. These enzymes have diversiﬁed
amino acid sequences and display a variety of biological activities. Pro-
tein glycosylation is a key post-translational modiﬁcation important to
a range of biological phenomena. Glycosylation is a frequent post-
translational modiﬁcation of snake venom proteins, which signiﬁcantly
contributes to venom proteome complexity [4,13–17]. Members of a
given toxin family may be differentially glycosylated or not glycosylat-
ed, while some speciﬁc toxins may display variable glycosylation levels
and are recognized as isozymes or proteoforms, however, very little is
known about the structure and size of carbohydrate moieties present
in venom glycoproteins [18–21].
Snake venom serine proteinases (SVSPs) may affect hemostatic
pathways by limited proteolysis that activates components involved in
coagulation, ﬁbrinolysis and platelet aggregation or by unspeciﬁc
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nization of the proteinase regions of serine proteinase genes, and of
the organization of the gene encoding the ﬁbrinogen-clotting enzyme
batroxobin, indicated that SVSPs evolved from glandular kallikrein, a
trypsin-like serine proteinase [23]. In addition, there are evidences at
the transcriptomic level that the SVSPs originated from kallikrein [24,
25]. Despite the fact that most SVSPs show some speciﬁc activity on
components of the coagulation cascade, various lines of evidence sug-
gest that the SVSPs, which share a common tertiary structurewith tryp-
sin, do not belong to the thrombin gene family and evolved to serve
other functions. Most SVSPs are single-chain glycoproteins showing
around 233 amino acid residues and a variable number of putative N-
or O-glycosylation sites in sequence positions that are not conserved.
Bothrops venoms contain various serine proteinases that function simi-
larly to enzymes of the coagulation/ﬁbrinolysis system resulting in an
imbalance of hemostasis that is an important part of the envenomation
process [11,26,27]. In the venom transcriptome/proteome of Bothrops
jararaca the abundance of serine proteinases increases from ~3% to
~8% upon newborn to adult transition [14,28].
PA-BJ is a basic serine proteinase of B. jararaca venom that has been
extensively characterized. PA-BJ causes 95% platelet aggregation in
platelet-rich plasma at a concentration of 10−8 M. On washed platelet
suspensions it causes 40% aggregation at a concentration of 10−7 M
[29,30]. Its amino acid sequencewas determined by Edman degradation
and shows one N-glycosylation (Asn20) and one O-glycosylation site
(Ser23). The effect of PA-BJ on platelets is mediated by the thrombin re-
ceptors PAR1 and PAR4, which are platelet receptors attached to G pro-
tein [31]. In vitro, PA-BJ cleaves the recombinant exodomain of human
receptor PAR1 on the Arg41–Ser42 and Arg46–Asn47 bonds, resulting
in the inactivation of the tethered ligand. Moreover, PA-BJ promotes
the release of calcium in ﬁbroblasts transfected with PAR4 and makes
these cells resistant to the action of thrombin [31]. PA-BJ cleaves p-
nitroaniline from several synthetic substrates containing Arg at the scis-
sile bond. The benzamidine derivative N-[(2-naphthylsulfonyl)-glycyl]-
4-amidinophenylalanine piperidide inhibits the amidolytic activity of
PA-BJ with a Ki value of 15 μM. The platelet-aggregating activity of PA-
BJ is also inhibited by heparin and by monoclonal antibodies recogniz-
ing PAR1 but not by hirudin and thrombomodulin [31].
PA-BJ has been isolated from the venomof B. jararaca by amulti-step
procedure composed of precipitation with 50–90% ammonium sulfate
followed by chromatographic steps on DEAE-Sephacel, SP-Sephadex
C-50 and Mono-S, including a rechromatography on the latter, which
results in a homogeneous preparation of the enzyme [29]. The goal of
this study was to establish a less complex method to purify PA-BJ and,
interestingly, the procedure we used enabled us to identify eight differ-
ent proteoforms of PA-BJ (PA-BJ 1–8) showing variable isoelectric
points and molecular masses, however, displaying similar activity
upon human platelets. To further elucidate the relationship between
structure and function of PA-BJ we explored its carbohydrate moieties
by submitting the proteoforms to deglycosylation with N- and O-
glycosidase under non-denaturing and denaturing conditions, and com-
pared their activities upon the recombinant exodomain of receptor
PAR1. Furthermore, we examined the possibility of the existence of
transcripts encoding SVSPs similar to PA-BJ in the venom gland of
B. jararaca.
2. Materials and methods
2.1. Isolation of PA-BJ
Lyophilized B. jararaca venom (100 mg) (Institute Butantan, São
Paulo, Brazil) was dissolved in 2 mL of 50 mM sodium phosphate buffer
pH 7.0 (Buffer A), and the turbid solution was clariﬁed by centrifugation
(1600 g; 20min; 4 °C) and the supernatantwas submitted to cationic ex-
change chromatographyonaHiPrep 16/10 SPXL column(GEHealthcare)
using Buffer A and 50mM sodiumphosphate buffer pH 7.0 plus 1MNaCl(Buffer B) for elution in an Äkta puriﬁer FPLC system (GE Healthcare)
(Fig. 1). Fractions containing PA-BJ were submitted to cationic exchange
chromatography on a Mono S HR 5/5 column (GE Healthcare) using the
same buffers of the previous chromatography. The resulting fractions
eluted with 20–35mLwere combined in three pools (Fig. 2). To improve
the separation of PA-BJ different forms, these three pools were separately
rechromatographedon theMono SHR5/5 columnusing adecreased con-
centration of the NaCl gradient or a higher volume of the NaCl gradient
(Fig. 3). After each chromatography the electrophoretic proﬁle of some
fractions was visualized by SDS-PAGE (12% polyacrylamide gel). Before
submitting each protein pool to the next chromatographic step they
were lyophilized, redissolved in ultra-puriﬁed water, dialyzed in Buffer
A and the concentration of proteins was determined.
2.2. Analytical procedures
Protein concentrations were determined by the Bradford protein
assay using bovine serum albumin as a standard. Sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE)was carried out ac-
cording to [32] and gels were stained with silver.
2.3. Mass spectrometric identiﬁcation of PA-BJ
Protein bands containing PA-BJ 1–8 were excised from the SDS-
polyacrylamide gel and submitted to in-gel trypsin digestion [33] and
mass spectrometric analysis by LC–MS/MS. For the mass spectrometric
analysis 5 μL of the resulting peptide mixture was separated by
reversed-phase chromatography in 5 cm Jupiter column (Phenomex)
packed with 10 μm C18 resin in tandem with a 10 cm Aqua column
(Phenomex) packed with 5 μm C18 resin at a ﬂow rate of 200 nL/min
in an Easy-nLC II (Thermo Scientiﬁc). The elution gradient was 5–40%
acetonitrile in 0.1% formic acid over 25 min. The eluate was applied to
a LTQ Orbitrap Velos (Thermo Scientiﬁc) by an electrospray nano-ﬂow
interface with 2.0 kV on the capillary. For the MS, the spectrometer
was operated in positive mode, and spectra were acquired in the m/z
range of 200–2000 and resolution R = 30,000. The top 10 method was
used to proceedwith collision-induced dissociation. For theMS2 the fol-
lowing parameters were used: dynamic exclusion duration of 15 s; re-
peat duration of 30 s; exclusion list size of 500. Resulting fragment
spectra were searched using Mascot (version 2.4.1) against the NCBI
NR database restricted to the taxa Serpentes (25 211 entries;
downloaded on June 20th, 2011), with a peptide mass tolerance of
10ppmand fragmentmass tolerance of 0.5Da. Iodoacetamide derivative
of cysteine and oxidation of methionine were speciﬁed in MASCOT as
ﬁxed and variable modiﬁcations, respectively. Alternatively, the search
of spectra was carried out against the sequences of cDNAs encoding
PA-BJ-like proteins (BJARSVSP14, BJARSVSP16 and BJARSVSP22), using
the same criteria described above.
2.4. LC–MS analysis of PA-BJ 1–8
LC-MS proﬁling of intact PA-BJ 1–8was performed using an Easy-nLC
II (Thermo Scientiﬁc) nanoLC systemcoupled on-linewith a LTQOrbitrap
Velos mass spectrometer (Thermo Scientiﬁc). Samples of PA-BJ 1–8
(5 μg/5 μL) were loaded onto a 5 cm Jupiter column (Phenomex) packed
with 10 μmC18 resin in tandemwith a 10 cm Aqua column (Phenomex)
packedwith 5 μmC18 resin at a ﬂow rate of 200 nL/min in an Easy-nLC II
(Thermo Scientiﬁc). Chromatography was performed with solvent A
(0.1% formic acid in deionized water) and B (0.1% formic acid in acetoni-
trile) at a ﬂow rate of 200 nL/min using the following gradient: to 3% B in
1min; to 60% B in 60min; to 85%B in 3min; hold at 85%B for 5min; then
back to 3% B in 1 min; hold at 3% B for 21 min. Spray voltage was set at
2.1 kV and the instrument was operated in full scan (MS1) mode only
(in the m/z range of 300–2000) with a resolution at 400 m/z 100,000.
Spectra deconvolution was carried out using the software Protein
Deconvolution v. 3.0 (Thermo Scientiﬁc).
Fig. 1. Fractionation of B. jararaca venom by cation-exchange chromatography on a HiPrep 16/10 SP XL column. 2mL of a B. jararaca venom solution containing 50mg/mL in 50mMphos-
phate buffer pH 7.0were submitted to chromatography on aHiPrep 16/10 SPXL columnusing 50mMphosphate buffer pH7.0 (Buffer A) and 50mMphosphate buffer pH 7.0 containing 1
MNaCl (Buffer B) for elution in anÄkta puriﬁer FPLC system. The double-headed arrow indicates the fractions that were combined for further puriﬁcation on aMono S column. Inset: SDS-
PAGE (12% gel) analysis of the protein peaks eluted from the Hi Prep SP column. Lane M, molecular mass markers; lane In, B. jararaca venom. Proteins were stained with silver.
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Total RNA from the venom glands of a single specimen of B. jararaca
was extracted with TRIZOL Reagent (Life Technologies) and mRNA was
prepared with Dynabeads® mRNA DIRECT kit (Life Technologies).
mRNA was quantiﬁed by Quant-iT™ RiboGreen® RNA reagent and Kit
(Life Technologies). A cDNA library was constructed from 500 ng of
mRNAusing cDNA Synthesis Systemkit (RocheDiagnostics). The library
was pyrosequenced in a GS Junior 454 Sequencing System (Roche Diag-
nostics) following the manufacturer's protocols. Sequences were as-
sembled with Newbler 2.7 (Roche Diagnostics), which removed
adaptors and ribosomal RNA sequences in an initial step. A minimum
overlap length of 80% of the read and a minimum identity of 98% in
the overlap were set, with the other parameters set as the software de-
fault. Isotigs were subjected to a Blast search against serine proteinases
downloaded from GenBank and UniProt databases with the BlastXFig. 2. Cation-exchange chromatography on aMono S column of fractions from the chromatogra
activity (indicated by a double-headed arrow on Fig. 1) were equilibrated in 50 mM phosphate
phate buffer pH 7.0 (Buffer A) and 50mMphosphate buffer pH 7.0 containing 1MNaCl (Buffer
tions that were combined into pools (1–3) for rechromatography. Inset: SDS-PAGE (12% gel)
markers; lane In, pooled fractions from the HiPrep column. Proteins were stained with silver.algorithm, and those showing a high degree of similarity to PA-BJ
were selected and checked by remapping reads to consensus and verify-
ing each base position to conﬁrm differences between the isoforms
using CLC Genomics Workbench (CLC, Qiagen).
2.6. Deglycosylation of PA-BJ proteoforms
For deglycosylation under denaturing conditions, samples of PA-BJ
1–8 (1 μg) were incubated in 10% SDS for 1 min at 95 °C. After adding
0.02 M sodium phosphate, 0.08% sodium azide, 0.01 M EDTA, 2% Triton
X-100, pH 7.0, and the incubation was prolonged for 2 min at 95 °C.
After cooling, 0.1 U of N-glycosidase F or 0.2 mU of O-glycosidase
(Roche) was added, and the mixture was incubated for 18 h at 37 °C.
For deglycosylation under non-denaturing conditions PA-BJ 1–8
samples (1 μg) were incubated in 0.02 M sodium phosphate buffer,
pH 7.2, 0.01 M EDTA, with 0.1 U of N-glycosidase F or 0.2 mU of O-phy of B. jararaca venomon a HiPrep SP column. Fractions containing platelet-aggregating
buffer pH 7.0 and submitted to chromatography on a Mono S HR 5/5 using 50 mM phos-
B) for elution in an Äkta puriﬁer FPLC system. The double-headed arrows indicate the frac-
analysis of the protein peaks eluted from the Mono S column. Lane M, molecular mass
Fig. 3.Rechromatography onMono S of fractions from B. jararaca venomcontainingplatelet-aggregating activity. The pools 1–3 from the chromatography onMono S (indicated bydouble-
headed arrows on Fig. 2) were equilibrated in 50 mM phosphate buffer pH 7.0 and submitted to rechromatography on a Mono S HR 5/5 using 50 mM phosphate buffer pH 7.0 (Buffer
A) and 50 mM phosphate buffer pH 7.0 containing 1 M NaCl (Buffer B) for elution in an Äkta puriﬁer FPLC system. The arrows indicate the peaks containing the isolated proteoforms
of PA-BJ. (A) rechromatography of pool 1; (B) rechromatography of pool 2; (C) rechromatography of pool 3.
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37 °C.
After incubation with the glycosidases the mixtures were submitted
to SDS-PAGE (12% polyacrylamide gel) and proteins were stained with
silver.
2.7. Homology modeling of PA-BJ
A tridimensionalmodel of native PA-BJ [29]was generated using the
Modeller 9v12 program [34] and the crystal structure of TSV-PA, a SVSP
which is a plasminogen activator from the venom of Trimeresurus
stejnejeri (residues 25–258; PDB entry 1BQY) and shows 74% sequence
identity to PA-BJ, as a template. The modeled region includes 232 resi-
dues (6–237) of PA-BJ (Uniprot entry P81824). The bestmodelwas cho-
sen according to the MODELLER objective function and stereo chemical
analyses using PROCHECK [35], Verify 3D [36] and WhatIf [37]. Angle
distortions and rotamers were corrected using COOT [38]. The ﬁgures
were prepared using ‘The PyMOL Molecular Graphics System’, Version
1.2r3pre, Schrödinger, LLC. (http://www.pymol.org).
2.8. Platelet aggregation assays
Platelets were isolated from fresh blood donations. The washed
platelet suspensions (WPS) were prepared as described by Antunes
et al. [39], and adjusted to 5 × 1011/L in Tyrode buffer pH 7.4 containing
2mMCaCl2. Aliquots of 0.4 mL ofWPS were kept at 37 °C for 1 min be-
fore the addition of 0.01 mL 50 mM phosphate buffer, pH 7.0 (control)
or 0.01 mL PA-BJ proteoforms (1–8) (1 μg in 50 mM phosphate buffer,
pH 7.0) with bar stirring speed set at 1200 rpm at 37 °C in the
aggregometer Chrono-log 490 for 10 min. The aggregometer was cali-
brated by setting WPS to 0% and PBS to 100% aggregation.
2.9. Hydrolysis of PAR1
The recombinant soluble PAR1 exodomain, TR78 (residues 26–103,
molecular mass 8925 Da), was produced in Escherichia coli at the C-
terminal portion of a fusion protein, ketosteroid isomerase, and puriﬁed
by RP-HPLC using a C-18 column and eluted at 35% acetonitrile as de-
scribed by Kuliopulos et al. [40]. TR78 (2 μg) was incubated with PA-BJ
1–8 (20 ng) (enzyme to substrate ratio of 1:100 (w/w)) in 0.1 M Tris–
HCl, pH 8.0 for 2 h at 37 °C. The proteolysis proﬁle was analyzed by
SDS-PAGE (15% SDS-polyacrylamide gel).
3. Results and discussion
3.1. Isolation of PA-BJ
In order to achieve a less complex method to isolate PA-BJ, the
venom of B. jararacawas submitted to cationic exchange chromatogra-
phy on a HiPrep 16/10 column and fractions containing PA-BJ (Fig. 1)
were submitted to cationic exchange chromatography on a Mono S HR
5/5 column. All resulting fractions from the Mono S column contained
PA-BJ and showed slightly variable electrophoretic proﬁles and molecu-
lar masses by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
increasing isoelectric points, as they were eluted by increasing concen-
trations of NaCl (Fig. 2). To improve the separation of PA-BJ different
forms, the protein fractions of the Mono S column were combined in
three pools which were separately rechromatographed and eluted
using a decreased concentration of the NaCl gradient and using a higher
volume for the NaCl gradient compared to the previous chromatography
(Fig. 3). The rechromatography of pool 1 resulted in the separation into
PA-BJ forms 1–4, whereas pool 2 resulted in PA-BJ forms 5–7, which
eluted in partially separated peaks (Fig. 3). Rechromatography of pool
3 resulted in the separation of PA-BJ 8 from aminor contaminant (Fig. 3).
The determination of themolecularmass of PA-BJ forms 1–4 by SDS-
PAGE under reducing conditions showed values that varied between 30and 32 kDa, while PA-BJ forms 5–8 are more basic and showed higher
molecular masses (33–38 kDa) (Fig. 4A; Supplemental Table 1). The
molecular masses of PA-BJ 1–8 were also determined by submitting
the intact samples to liquid chromatography coupled to electrospray-
ionization (ESI) mass spectrometry. Deconvolution of the multiple-
charge spectra yielded isotope-averaged molecular masses for the
most intense signal of each PA-BJ form that ranged from ~25 kDa to
~30 kDa (Supplemental Fig. 1), however, in all samples, besides the
most intense signal, other low signals corresponding to close molecular
masses were detected indicating themicroheterogeneity of the isolated
PA-BJ forms. As PA-BJ is a glycosylated protein, the LC–MS proﬁles
showing microheterogeneity suggest the possible presence of different
glycan structures at the glycosylation sites of the isolated PA-BJ
proteoforms. Nevertheless, themolecularmasses of intact PA-BJ 1–8 ob-
tained by LC-MS are lower than those obtained by SDS-PAGE analysis of
reduced samples possibly due to the fact that under reducing conditions
the absence of disulﬁde bondsmakes proteins less compact and thereby
might inﬂuence their mobility on the gel.
Protein bands containing PA-BJ 1–8 (Fig. 4A) were excised and sub-
mitted to in-gel trypsin digestion and mass spectrometric analysis by
LC–MS/MS. The analysis resulted in the identiﬁcation of PA-BJ forms by
the sequencing of various fragments with high score (Supplemental
Table 1), which matched the sequence of PA-BJ obtained previously by
Edman degradation [29] (Uniprot entry P81824), however, the putative
tryptic peptide that contains the N- and O-glycosylation sites of PA-BJ
(R.SLVLLYNSSSLLCSGTLINQEWVLTAAHCDS.K) was not detected among
the spectra due to its long sequence. The identity of the eight PA-BJ
proteoforms was further conﬁrmed by testing their ability to activate
platelets. PA-BJ 1–8 (1 μg) showed similar potencies to aggregate
washed human platelet suspensions (Supplemental Fig. 2), indicating
that their different glycosylation levels do not play a role in their ability
to trigger the aggregation process. Two other SVSPs, KN-BJ and TL-BJ,
are present in the venom of B. jararaca in different proteoforms (KN-BJ
1-2 and TL-BJ 1-3) that also differ in isoelectric point and molecular
mass [18,41] however display similar kinin-releasing and ﬁbrinogen-
coagulant activities, respectively.
3.2. Deglycosylation of PA-BJ proteoforms
We next assessed the presence of carbohydrate moieties in the PA-BJ
proteoforms by submitting them toN- andO-deglycosylation under non-
denaturing conditions.N-glycosidase F is an enzyme able to remove Asn-
linked oligosaccharides (Asn-GlcNAc-glycans) from theprotein backbone
while O-glycosidase is used to release the Gal-beta(1,3)GaINAc unit from
O-glycans (attached to Ser or Thr residues). As shown in Fig. 4B, only a
very small fraction of the PA-BJ 1–4 forms was susceptible to N-glycosi-
dase F and O-glycosidase deglycosylation when the protein samples
were not denatured prior to incubationwith the glycosidases, as detected
by the generation of a very faint protein band of ~25 kDa which corre-
sponds to the deglycosylated form. On the other hand, PA-BJ 5–8 forms
likely contain larger carbohydrate moieties than PA-BJ 1–4, as judged
by their highermolecularmasses (Fig. 4A), and showed different electro-
phoretic proﬁles after N- and O-deglycosylation under non-denaturing
conditions (Fig. 4B). The glycosidases promoted only partial deglycosyla-
tion of PA-BJ 5–8, as observed by shifts of their apparent molecular
masses. Interestingly, these forms of PA-BJ showed variable proﬁles of
protein bands under non-denaturing deglycosylation conditions indicat-
ing that they display different susceptibilities to the activity of the glyco-
sidases. Indeed, only a small amount of PA-BJ 5–6 was apparently fully
deglycosylated while PA-BJ 7–8 were not (Fig. 4B).
Denaturation of proteins increases the deglycosylation rate consid-
erably. However, when PA-BJ 1–8 were denatured with SDS prior to
the incubation with the glycosidases they showed variable deglycosyla-
tion proﬁles and not all formswere fully deglycosylated (Fig. 4C and D).
The electrophoretic proﬁles of PA-BJ 1–8 after N-deglycosylation under





Fig. 4. SDS-PAGE (12% SDS-polyacrylamide gel) proﬁles of native and deglycosylated PA-BJ forms and predicted structure of PA-BJ usingmolecularmodeling. (A) Isolated PA-BJ 1–8 (1 μg)
from the rechromatography on Mono S column (Fig. 3). (B) PA-BJ 1–8 (1 μg) submitted to N- and O-deglycosylation under non-denaturing conditions. (C) and (D) PA-BJ 1–8 (1 μg) sub-
mitted to N-deglycosylation and O-deglycosylation, respectively, under denaturing conditions. Proteins were stained with silver. (E) Cartoon representations of the predicted structure of
PA-BJ using molecular modeling. The putative exosites I and II are indicated [42]. The N- and O-glycosylation sites Asn20 and Ser23 of PA-BJ are shown as a spheres representation in red.
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which underwent only partial deglycosylation (Fig. 4C). Moreover, in
the case of PA-BJ forms 3, 5, 6 and 7,multiple protein bands ofmolecular
masses of ~17 kDa and lower have been generated, which indicates a
certain degree of instability of these proteins after N-deglycosylation
(Fig. 4C). O-Deglycosylation under denaturing conditions also revealed
variable electrophoretic proﬁles between the PA-BJ forms. Only PA-BJ
4 was nearly fully O-deglycosylated and showed a molecular mass of
~26 kDa. PA-BJ 1–3 and 5–8 were partially O-deglycosylated and
showed variable molecular masses above 25 kDa, which correspond totheir partially deglycosylated polypeptide chains (Fig. 4D). Moreover,
although at different degrees, after O-deglycosylation PA-BJ forms
showed additional bands of molecular mass of ~17 kDa and below, as
a result of the possible structure instability induced by deglycosylation
(Fig. 4D). Glycosylation is one of the major post-translational modiﬁca-
tions in viperid venoms, and, as in other eukaryotic proteomes, should
signiﬁcantly affect protein folding, conformation, and activity. Likewise,
glycosylation confers stability on secreted glycoproteins and although it
is not a strict requisite for correct folding, unglycosylated proteins are
unstable. Taken together, our results indicate that the carbohydrate
Fig. 5. Electrophoretic proﬁle of the cleavage of the recombinant human PAR1 exodomain
(TR78) by native PA-BJ 1–8 (A) or PA-BJ 1–8 previously submitted to N- and O-
deglycosylation under non-denaturing conditions (B). PAR1 (2 μg) was incubated with
PA-BJ forms (20 ng) for 2 h, at 37 °C. Proteins were separated using 15% polyacrylamide
gels and stained with silver. Lane M, molecular mass markers. Lane C, PAR1 incubated
without enzyme for 2 h, at 37 °C. Numbers on the left indicate molecular mass marker
mobility.
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cess to the activity of N- and O-glycosidase. Moreover, removal of oligo-
saccharide chains likely affects the thermodynamic stability of some of
the PA-BJ proteoforms and makes them prone to degradation in solu-
tion, however, these different structural features do not seem to affect
their ability to activate platelets, which is similar (Supplemental Fig. 2).
With the purpose of investigating the spatial location of the N- and
O-glycosylation sites of PA-BJ, a tridimensional model of the protein
was predicted by homology modeling using the crystal structure of
TSV-PA, a plasminogen activator from T. stejnejeri venom, as a template.
As shown in Fig. 4E, PA-BJ belongs to the typical α/β-hydrolase fold of
serine proteinases where the residues of catalytic triad are located at
the junction of the two six-stranded beta-barrels. PA-BJ has two glyco-
sylated sites at Asn20 and Ser23, but the proportions of the carbohy-
drates within the isolated eight forms may be different, as judged by
their variable molecular masses. Nevertheless, the location of these car-
bohydrate chains in the modeled structure seems to be near the en-
trance to the catalytic cleft (Fig. 4E) and even if they protruded into
the cleft or into the space in front of the entrance to it, they would ap-
parently not hinder the interaction between PA-BJ and its ligands,
which likely occurs via exosites I and II located quite distant from the ac-
tive center [42]. On the other hand, the presence of carbohydrate chains
near the access to active site could hinder the interaction of PA-BJ with
serpins, and this seems to be the case, since all forms are capable of ac-
tivating platelets in platelet rich plasma (not shown) and hence escape
inhibition by plasma proteins.
3.3. Glycosylation and the activity of PA-BJ proteoforms on PAR1
In order to assess the effect of the variable carbohydrate chains in the
proteolytic activity of PA-BJ 1–8 these were incubated with the recom-
binant exodomain of receptor PAR1 (TR78; 8925 Da) [40] at a 1:100
enzyme-to-substrate ratio for 2 h at 37 °C. As shown in Fig. 5A, under
these conditions, PA-BJ 1–7 cleaved the protein and generated a main
product of ~6 kDa while PA-BJ 8 was only capable of degrading it par-
tially. We next tested the ability of the PA-BJ forms submitted to N-
and O-deglycosylation under non-denaturing conditions to cleave PAR
1 (Fig. 4B). Fig. 5B shows that apparently, except for PA-BJ 2, all other
partially deglycosylated enzymes had their ability to cleave PAR 1 im-
paired, suggesting that the removed carbohydrate chains might play a
role in the interaction of PA-BJ with the recombinant exodomain of re-
ceptor PAR1 in vitro. Alternatively, the partially removed carbohydrate
moieties could be important to keep the tertiary structure of the PA-BJ
forms and hence their proteolytic activity.
The presence of PA-BJ in different proteoforms showing variable iso-
electric points and molecular masses in the venom of B. jararaca is in-
triguing and likely occurs as a result of molecular ﬁne-tuning via
accelerated evolution [9] to diversify the toxin arsenal upon evolution
to deal with different types of prey. The role of structural N- and O-
glycans in the function of SVSPs is poorly known and studies aimed at
identifying their carbohydrate units as well as the mutation of sequons
should shed light on the structural requirements for the interaction of
these enzymes with their ligands.
3.4. Identiﬁcation of PA-BJ-like cDNAs in the venom gland of B. jararaca
The presence of multiple isozyme forms of serine proteinases in
snake venom glands has been reported in the Viperidae family. We
next examined the possibility of the existence of transcripts encoding
SVSPs similar to PA-BJ in the venom gland of B. jararaca, using a next
generation sequence approach. Hence, RNA from the venom glands of
a single specimen of B. jararaca was extracted and used to construct a
cDNA library, which was submitted to pyrosequencing. As a result,
three full-length cDNAs encoding PA-BJ-like serine proteinases
(BJARSVSP14, BJARSVSP16 and BJARSVSP22) were identiﬁed (Fig. 6A).
An alignment of the sequence region corresponding to the matureformof these serine proteinases and PA-BJ showed83% of amino acid se-
quence identity. The theoretical isoelectric points of themature forms of
these PA-BJ-like proteins range from 9.37 to 9.59 and are slightly above
that of PA-BJ (9.08) (Fig. 6B). In addition to the N-glycosylation site at
Asn20, which has been determined by Edman degradation sequencing
[29], the three PA-BJ-like enzymes show one putative N-glycosylation
site at the C-terminal region that is absent in PA-BJ (Fig. 6A). Although
the transcripts of PA-BJ-like proteins also contain a conserved Ser resi-
due at position 23, which is occupied by a carbohydrate chain in PA-BJ
[29], this was not considered as a potential O-glycosylation site since it
is not part of any consensus sequence for glycosylation and it is not pre-
dicted as being glycosylated by the NetOGlyc 4.0 Server (at www.
expasy.org). The number of amino acid substitutions in the amino acid
sequence of BJARSVSP14, BJARSVSP16 and BJARSVSP22 compared to
PA-BJ is variable (20, 40 and 12, respectively), however, these substitu-
tions did not signiﬁcantly affect their theoretical isoelectric points and
molecular masses, and putative glycosylation sites (Fig. 6B).
We next carried out a new search of the fragment spectra obtained
by the in gel trypsin digestion of protein bands containing PA-BJ 1–8
(Fig. 4A) against the sequences of BJARSVSP14, BJARSVSP16 and
BJARSVSP22 which resulted in the identiﬁcation of tryptic peptides be-
longing to these sequences in the PA-BJ forms 5–8 but not in PA-BJ
forms 1–4 (Supplemental Table 2). These results are in agreement
AB
Fig. 6. Sequencing of cDNAs encoding PA-BJ-like serine proteinases in the venom gland of B. jararaca. (A) Amino acid sequence comparison of PA-BJ (SwissProt entry P81824) with three
cDNAs encoding serine proteinases similar to PA-BJ. The sequences of the putative mature proteins are shown. The numbering starts from the N-terminal residue of PA-BJ. Gaps were in-
troduced to improve alignment. Residues of the catalytic triad are indicated by asterisks. Residues different from PA-BJ are indicated in red letters. Potential glycosylation sites of the cDNA
encoding serine proteinase sequences and the experimentally determined glycosylation sites of PA-BJ [29] are shown in underlined green letters. (B) Comparison of protein parameters of
PA-BJ and PA-BJ-like serine proteinases.
2075E.T. Yamashiro et al. / Biochimica et Biophysica Acta 1844 (2014) 2068–2076with the fact that the isolated proteoforms 5–8 are more basic than 1–4
and the sequences of the PA-BJ-like proteins show theoretical isoelectric
points somewhat higher than that of PA-BJ (Uniprot entry P81824)
(Fig. 6B). Thus, these results suggest that in the protein bands corre-
sponding to proteoforms 5–8 (Fig. 4A), a mixture of the PA-BJ (Uniprot
entry P81824) and PA-BJ-like proteins is present. The lack of a transcript
encoding a sequence identical to PA-BJ in the cDNA library of the venom
glands of B. jararaca is due to the fact that this library was constructed
with RNA isolated from one specimen, which likely lacked an mRNA
that matched that of PA-BJ, and is related to the individual variation oc-
curring in B. jararaca venom [2,43].
Deshimaru and colleagues observed that the SVSP genes form a
multigene family, and showed that nonsynonymous nucleotide substi-
tutions have accumulated at a high rate in the mature protein-coding
regions to cause amino acid changes that diversiﬁed their enzymatic ac-
tivities [9]. In this study, pyrosequencing of a cDNA library of the venom
gland of B. jararaca resulted in the identiﬁcation of 13 full-length se-
quences encoding SVSPs (not shown) among which three are similar
to PA-BJ. Interestingly, no cDNA encoding a SVSP showing 100% identity
to PA-BJ (Uniprot entry P81824) was identiﬁed in the library likely due
to the fact that it was constructed using RNA isolated from the venom
glands of a single B. jararaca specimen. These results indicate that inagreement with the isolation of eight proteoforms of PA-BJ from the
venom of B. jararaca, different mRNAs encoding PA-BJ-like enzymes
may be present in the venom glands and contribute to the proteome
complexity. Taken together, the ﬁndings of this study support the con-
cept that the characterization of snake venom proteomes requires
hypothesis-driven research and technology-driven approaches inte-
grated in an experimental strategy that includes decomplexation of
the venom proteome prior to LC–MS/MS and a species-speciﬁc tran-
scriptome [44]. In this regard, our study emphasizes the validity of
this concept to the characterization of proteoforms of a speciﬁc toxin.
4. Conclusions
Variation in snake venom proteomes is considered a consequence of
gene duplication and accelerated molecular evolution to provide the
venom with a dynamic repertoire of toxins and increase the diversity
of molecules to deal with prey targets. In this study we isolated eight
proteoforms of the serine proteinase PA-BJ in B. jararaca venom that
clearly differ in their isoelectric points, glycosylation levels, and suscep-
tibilities to enzymatic deglycosylation. The reason for the presence of
multiple proteoforms of this serine proteinase in the venom is unknown
but it might be related to its ability to interact with prey platelets as
2076 E.T. Yamashiro et al. / Biochimica et Biophysica Acta 1844 (2014) 2068–2076B. jararacamay feed on different small mammals during adult life. Be-
sides the variation regarding the presence or absence of typical toxin
families and the relative amount of members within a toxin family,
the variability of proteoforms of a speciﬁc toxin adds one more level
to snake venom proteome complexity.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbapap.2014.09.012.
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